Proteomic patterns: Their potential for disease diagnosis

Molecular and Cellular Endocrinology

Volumn 230, Issue 1-2, 2005, Pages 95-106

  Xiao, Zhen ^a   Prieto, Darue ^a   Conrads, Thomas P ^a   Veenstra, Timothy D ^a   Issaq, Haleem J ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Biomarker discovery; Cancer; Proteomic patterns; SELDI

Indexed keywords

AMYLOID BETA PROTEIN; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CYSTATIN C; PROSTATE SPECIFIC ANTIGEN; PROTEIN; PROTEIN SELDI; PROTEOME; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALZHEIMER DISEASE; BREAST CANCER; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; HUMAN; IMMUNOASSAY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN MICROARRAY; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

EID: 12344272902     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2004.10.010     Document Type: Article

References (66)

1. B.L. Adam, Y. Qu, J.W. Davis, M.D. Ward, M.A. Clements, L.H. Cazares, O.J. Semmes, P.F. Schellhammer, Y. Yasui, Z. Feng, and G.L. Wright Jr. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men Cancer Res. 62 2002 3609 3614
2. A.A. Alaiya, U.J. Roblick, B. Franzen, H.P. Bruch, and G. Auer Protein expression profiling in human lung, breast, bladder, renal, colorectal and ovarian cancers J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 787 2003 207 222
3. Y.G. Amaar, G.R. Thompson, T.A. Linkhart, S.T. Chen, D.J. Baylink, and S. Mohan Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2) J. Biol. Chem. 277 2002 12053 12060
4. N.L. Anderson, and N.G. Anderson The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 1 2002 845 867
5. K.A. Baggerly, J.S. Morris, and K.R. Coombes Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments Bioinformatics 20 2004 777 785
6. L.L. Banez, P. Prasanna, L. Sun, A. Ali, Z. Zou, B.L. Adam, D.G. McLeod, J.W. Moul, and S. Srivastava Diagnostic potential of serum proteomic patterns in prostate cancer J. Urol. 170 2003 442 446
7. A.C. Bergman, T. Benjamin, A. Alaiya, M. Waltham, K. Sakaguchi, B. Franzen, S. Linder, T. Bergman, G. Auer, E. Appella, P.J. Wirth, and H. Jornvall Identification of gel-separated tumor marker proteins by mass spectrometry Electrophoresis 21 2000 679 686
8. E. Caputo, A. Camarca, R. Moharram, P. Tornatore, B. Thatcher, J. Guardiola, and B.M. Martin Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach Biochemistry 42 2003 6169 6178
9. M.H. Cardone, N. Roy, H.R. Stennicke, G.S. Salvesen, T.F. Franke, E. Stanbridge, S. Frisch, and J.C. Reed Regulation of cell death protease caspase-9 by phosphorylation Science 282 1998 1318 1321
10. O. Carrette, I. Demalte, A. Scherl, O. Yalkinoglu, G. Corthals, P. Burkhard, D.F. Hochstrasser, and J.C. Sanchez A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease Proteomics 3 2003 1486 1494
11. D. Carter, J.F. Douglass, C.D. Cornellison, M.W. Retter, J.C. Johnson, A.A. Bennington, T.P. Fleming, S.G. Reed, R.L. Houghton, D.L. Diamond, and T.S. Vedvick Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer Biochemistry 41 2002 6714 6722
12. P. Chaurand, S.A. Schwartz, and R.M. Caprioli Assessing protein patterns in disease using imaging mass spectrometry J. Proteome Res. 3 2004 245 252
13. A. Chernyak, A. Karavanov, Y. Ogawa, and P. Kovac Conjugating oligosaccharides to proteins by squaric acid diester chemistry: rapid monitoring of the progress of conjugation, and recovery of the unused ligand Carbohydr. Res. 330 2001 479 486
14. T.P. Conrads, V.A. Fusaro, S. Ross, D. Johann, V. Rajapakse, B.A. Hitt, S.M. Steinberg, E.C. Kohn, D.A. Fishman, G. Whitely, J.C. Barrett, L.A. Liotta, E.F. Petricoin III, and T.D. Veenstra High-resolution serum proteomic features for ovarian cancer detection Endocr. Relat. Cancer 11 2004 163 178
15. K.R. Coombes, H.A. Fritsche Jr., C. Clarke, J.N. Chen, K.A. Baggerly, J.S. Morris, L.C. Xiao, M.C. Hung, and H.M. Kuerer Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization Clin. Chem. 49 2003 1615 1623
16. C.E. Forde, A.D. Gonzales, J.M. Smessaert, G.A. Murphy, S.J. Shields, J.P. Fitch, and S.L. McCutchen-Maloney A rapid method to capture and screen for transcription factors by SELDI mass spectrometry Biochem. Biophys. Res. Commun. 290 2002 1328 1335
17. C.E. Forde, and S.L. McCutchen-Maloney Characterization of transcription factors by mass spectrometry and the role of SELDI-MS Mass Spectrom. Rev. 21 2002 419 439
18. L.J. Fowler, M.O. Lovell, and E. Izbicka Fine-needle aspiration in PreservCyt: a novel and reproducible method for possible ancillary proteomic pattern expression of breast neoplasms by SELDI-TOF Mod. Pathol. 17 2004 1012 1020
19. L.E. Goldstein, J.A. Muffat, R.A. Cherny, R.D. Moir, M.H. Ericsson, X. Huang, C. Mavros, J.A. Coccia, K.Y. Faget, K.A. Fitch, C.L. Masters, R.E. Tanzi, L.T. Chylack Jr., and A.I. Bush Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease Lancet 361 2003 1258 1265
20. N.I. Govorukhina, A. Keizer-Gunnink, A.G.J. van der Zee, S. de Jong, H.W.A. de Bruijn, and R. Bischoff Sample preparation of human serum for the analysis of tumor markers - comparison of different approaches for albumin and gamma-globulin depletion J. Chromatogr. A 1009 2003 171 178
21. W.E. Grizzle, B.L. Adam, W.L. Bigbee, T.P. Conrads, C. Carroll, Z. Feng, E. Izbicka, M. Jendoubi, D. Johnsey, J. Kagan, R.J. Leach, D.B. McCarthy, O.J. Semmes, S. Srivastava, I.M. Thompson, M.D. Thornquist, M. Verma, Z. Zhang, and Z. Zou Serum protein expression profiling for cancer detection: validation of a SELDI-based approach for prostate cancer Dis. Markers 19 2003 185 195
22. W.E. Grizzle, O.J. Semmes, J. Basler, E. Izbicka, Z. Feng, J. Kagan, B.L. Adam, D. Troyer, S. Srivastava, M. Thornquist, Z. Zhang, and I.M. Thompson The early detection research network surface-enhanced laser desorption and ionization prostate cancer detection study: a study in biomarker validation in genitourinary oncology Urol. Oncol. 22 2004 337 343
23. Q.Y. He, J. Chen, H.F. Kung, A.P. Yuen, and J.F. Chiu Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics Proteomics 4 2004 271 278
24. H.J. Issaq, T.P. Conrads, D.A. Prieto, R. Tirumalai, and T.D. Veenstra SELDI-TOF MS for diagnostic proteomics Anal. Chem. 75 2003 148A 155A
25. A. Jemal, R.C. Tiwari, T. Murray, A. Ghafoor, A. Samuels, E. Ward, E.J. Feuer, and M.J. Thun Cancer statistics CA Cancer J. Clin. 54 2004 8 29
26. J. Koopmann, Z. Zhang, N. White, J. Rosenzweig, N. Fedarko, S. Jagannath, M.I. Canto, C.J. Yeo, D.W. Chan, and M. Goggins Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry Clin. Cancer Res. 10 2004 860 868
27. K.R. Kozak, M.W. Amneus, S.M. Pusey, F. Su, M.N. Luong, S.A. Luong, S.T. Reddy, and R. Farias-Eisner Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis Proc. Natl. Acad. Sci. U.S.A. 100 2003 12343 12348
28. L.C. Lawrie, S. Curran, H.L. McLeod, J.E. Fothergill, and G.I. Murray Application of laser capture microdissection and proteomics in colon cancer Mol. Pathol. 54 2001 253 258
29. S. Lehrer, J. Roboz, H. Ding, S. Zhao, E.J. Diamond, J.F. Holland, N.N. Stone, M.J. Droller, and R.G. Stock Putative protein markers in the sera of men with prostatic neoplasms BJU Int. 92 2003 223 225
30. P. Lewczuk, H. Esselmann, M. Meyer, V. Wollscheid, M. Neumann, M. Otto, J.M. Maler, E. Ruther, J. Kornhuber, and J. Wiltfang The amyloid-beta (Abeta) peptide pattern in cerebrospinal fluid in Alzheimer's disease: evidence of a novel carboxyterminally elongated Abeta peptide Rapid Commun. Mass Spectrom. 17 2003 1291 1296
31. P. Lewczuk, H. Esselmann, T.W. Groemer, M. Bibl, J.M. Maler, P. Steinacker, M. Otto, J. Kornhuber, and J. Wiltfang Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease Biol. Psychiatry 55 2004 524 530
32. J. Li, Z. Zhang, J. Rosenzweig, Y.Y. Wang, and D.W. Chan Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer Clin. Chem. 48 2002 1296 1304
33. J. Li, N. White, Z. Zhang, J. Rosenzweig, L.A. Mangold, A.W. Partin, and D.W. Chan Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population J. Urol. 171 2004 1782 1787
34. J.S. MacNeil Better biomarkers for the diagnostics labyrinth Genome Technol. 2004 24 33
35. N. Neuhoff, T. Kaiser, S. Wittke, R. Krebs, A. Pitt, A. Burchard, A. Sundmacher, B. Schlegelberger, W. Kolch, and H. Mischak Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry Rapid Commun. Mass Spectrom. 18 2004 149 156
36. D.K. Ornstein, W. Rayford, V.A. Fusaro, T.P. Conrads, S.J. Ross, B.A. Hitt, W.W. Wiggins, T.D. Veenstra, L.A. Liotta, and E.F. Petricoin III Serum proteomic profiling can discriminate prostate cancer from benign prostates in men with total prostate specific antigen levels between 2.5 and 15.0 mg/ml J. Urol. 172 2004 1302 1305
37. C.P. Paweletz, D.K. Ornstein, M.J. Roth, V.E. Bichsel, J.W. Gillespie, V.S. Calvert, C.D. Vocke, S.M. Hewitt, P.H. Duray, J. Herring, Q.H. Wang, N. Hu, W.M. Linehan, P.R. Taylor, L.A. Liotta, M.R. Emmert-Buck, and E.F. Petricoin III Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma Cancer Res. 60 2000 6293 6297
38. C.P. Paweletz, B. Trock, M. Pennanen, T. Tsangaris, C. Magnant, L.A. Liotta, and E.F. Petricoin III Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer Dis. Markers 17 2001 301 307
39. E.F. Petricoin III, A.M. Ardekani, B.A. Hitt, P.J. Levine, V.A. Fusaro, S.M. Steinberg, G.B. Mills, C. Simone, D.A. Fishman, E.C. Kohn, and L.A. Liotta Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572 577
40. E.F. Petricoin III, D.K. Ornstein, C.P. Paweletz, A. Ardekani, P.S. Hackett, B.A. Hitt, A. Velassco, C. Trucco, L. Wiegand, K. Wood, C.B. Simone, P.J. Levine, W.M. Linehan, M.R. Emmert-Buck, S.M. Steinberg, E.C. Kohn, and L.A. Liotta Serum proteomic patterns for detection of prostate cancer J. Natl. Cancer Inst. 94 2002 1576 1578
41. E.F. Petricoin III, and L.A. Liotta SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer Curr. Opin. Biotechnol. 15 2004 24 30
42. D. Prieto, T.P. Conrads, D.A. Scudiero, T.D. Veenstra, and H.J. Issaq Profiling of secreted proteins from human ovarian cancer cell lines by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry J. Liquid Chromatogr. Relat. Technol. 26 2003 2315 2328
43. L. Pusztai, B.W. Gregory, K.A. Baggerly, B. Peng, J. Koomen, H.M. Kuerer, F.J. Esteva, W.F. Symmans, P. Wagner, G.N. Hortobagyi, C. Laronga, O.J. Semmes, G.L. Wright Jr., R.R. Drake, and A. Vlahou Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma Cancer 100 2004 1814 1822
44. Y. Qu, B.L. Adam, Y. Yasui, M.D. Ward, L.H. Cazares, P.F. Schellhammer, Z. Feng, O.J. Semmes, and G.L. Wright Jr. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients Clin. Chem. 48 2002 1835 1843
45. A.J. Rai, Z. Zhang, J. Rosenzweig, M. Shih Ie, T. Pham, E.T. Fung, L.J. Sokoll, and D.W. Chan Proteomic approaches to tumor marker discovery Arch. Pathol. Lab. Med. 126 2002 1518 1526
46. B. Rockhill Proteomic patterns in serum and identification of ovarian cancer Lancet 360 2002 169 (Author reply 170-171)
47. E.R. Sauter, W. Zhu, X.J. Fan, R.P. Wassell, I. Chervoneva, and G.C. Du Bois Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer Br. J. Cancer 86 2002 1440 1443
48. M. Shiwa, Y. Nishimura, R. Wakatabe, A. Fukawa, H. Arikuni, H. Ota, Y. Kato, and T. Yamori Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform Biochem. Biophys. Res. Commun. 309 2003 18 25
49. T. Uchida, A. Fukawa, M. Uchida, K. Fujita, and K. Saito Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid J. Proteome Res. 1 2002 495 499
50. J. Villanueva, J. Philip, D. Entenberg, C.A. Chaparro, M.K. Tanwar, E.C. Holland, and P. Tempst Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry Anal. Chem. 76 2004 1560 1570
51. A. Vlahou, P.F. Schellhammer, S. Mendrinos, K. Patel, F.I. Kondylis, L. Gong, S. Nasim, and G.L. Wright Jr. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine Am. J. Pathol. 158 2001 1491 1502
52. J.T. Wadsworth, K.D. Somers, L.H. Cazares, G. Malik, B.L. Adam, B.C. Stack Jr., G.L. Wright Jr., and O.J. Semmes Serum protein profiles to identify head and neck cancer Clin. Cancer Res. 10 2004 1625 1632
53. M. Wagner, D.N. Naik, A. Pothen, S. Kasukurti, R.R. Devineni, B.L. Adam, O.J. Semmes, and G.L. Wright Jr. Computational protein biomarker prediction: a case study for prostate cancer BMC Bioinform. 5 2004 26
54. S. Wang, D.L. Diamond, G.M. Hass, R. Sokoloff, and R.L. Vessella Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by ProteinChip; array, surface-enhanced laser desorption/ionization (SELDI) technology Int. J. Cancer 92 2001 871 876
55. E.M. Weissinger, S. Wittke, T. Kaiser, H. Haller, S. Bartel, R. Krebs, I. Golovko, H.D. Rupprecht, M. Haubitz, H. Hecker, H. Mischak, and D. Fliser Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes Kidney Int. 65 2004 2426 2434
56. Y.F. Wong, T.H. Cheung, K.W. Lo, V.W. Wang, C.S. Chan, T.B. Ng, T.K. Chung, and S.C. Mok Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix Cancer Lett. 211 2004 227 234
57. ® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures Prostate Cancer Prostatic Dis. 2 1999 264 276
58. J.D. Wulfkuhle, K.C. McLean, C.P. Paweletz, D.C. Sgroi, B.J. Trock, P.S. Steeg, and E.F. Petricoin III New approaches to proteomic analysis of breast cancer Proteomics 1 2001 1205 1215
59. X. Xiao, D. Liu, Y. Tang, F. Guo, L. Xia, J. Liu, and D. He Development of proteomic patterns for detecting lung cancer Dis. Markers 19 2003 33 39
60. Z. Xiao, X. Jiang, M.L. Beckett, and G.L. Wright Jr. Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay Protein Expr. Purif. 19 2000 12 21
61. Z. Xiao, B.L. Adam, L.H. Cazares, M.A. Clements, J.W. Davis, P.F. Schellhammer, E.A. Dalmasso, and G.L. Wright Jr. Quantitation of serum prostate-specific membrane antigen by a novel protein biochip immunoassay discriminates benign from malignant prostate disease Cancer Res. 61 2001 6029 6033
62. Z. Xiao, B.T. Luke, G. Izmirlian, A. Umar, P.M. Lynch, R.K. Phillips, S. Patterson, T.P. Conrads, T.D. Veenstra, P. Greenwald, E.T. Hawk, and I.U. Ali Serum proteomic profiles suggest celecoxib-modulated targets and response predictors Cancer Res. 64 2004 2904 2909
63. Y. Yasui, M. Pepe, M.L. Thompson, B.L. Adam, G.L. Wright Jr., Y. Qu, J.D. Potter, M. Winget, M. Thornquist, and Z. Feng A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection Biostatistics 4 2003 449 463
64. B. Ye, D.W. Cramer, S.J. Skates, S.P. Gygi, V. Pratomo, L. Fu, N.K. Horick, L.J. Licklider, J.O. Schorge, R.S. Berkowitz, and S.C. Mok Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry Clin. Cancer Res. 9 2003 2904 2911
65. L. Zhang, W. Yu, T. He, J. Yu, R.E. Caffrey, E.A. Dalmasso, S. Fu, T. Pham, J. Mei, J.J. Ho, W. Zhang, P. Lopez, and D.D. Ho Contribution of human alpha-defensin 1, 2 and 3 to the anti-HIV-1 activity of CD8 antiviral factor Science 298 2002 995 1000
66. Z. Zhang, R.C. Bast Jr., Y. Yu, J. Li, L.J. Sokoll, A.J. Rai, J.M. Rosenzweig, B. Cameron, Y.Y. Wang, X.Y. Meng, A. Berchuck, C. Van Haaften-Day, N.F. Hacker, H.W. de Bruijn, A.G. van der Zee, I.J. Jacobs, E.T. Fung, and D.W. Chan Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res. 64 2004 5882 5890